Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Treasury Stock (2026)

Updated

Analysis

Korro Bio (KRRO) Treasury Stock (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Stock (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -3.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 76.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.62 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 64.59 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.20 Bn
10 Korro Bio 281.05 Mn -128.11 Mn - 12.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.12 Mn
API Access

Korro Bio Treasury Stock API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=KRRO&period=max&api_key=YOUR_API_KEY